Fuso Pharmaceutical Industries, Ltd.
扶桑薬品工業株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4538
FY2025 · 2026-03-31
| Gross margin | 25.7% |
| Operating margin | 4.2% |
| Net margin | 3.2% |
| Return on equity | — |
| Return on assets | 2.2% |
| Revenue growth (YoY) | 2.9% |
| EPS (basic) | ¥235.63 |
| EPS growth (YoY) | — |
| Current ratio | 1.11x |
| Equity ratio | 41.0% |
| Book value / share | ¥4,106.51 |
| Free cash flow | -7,490 M |